Logo
Home
Company ProfileBoards & StaffsMemberships & PartnersAcademy of JournalismCareersBlog(EN)Contact Us
Our JournalsInstruction for AuthorsBrieflands PoliciesPublish My ResearchJournal Management SystemArticle Processing ChargesOpen Peer ReviewPublishing Services
Publish My Book
  1. Brieflands
  2. journals
  3. Hepatitis Monthly
  4. Articles

  5. Is Combination Therapy for Chronic Hepatitis C Toxic for Cardiac Function?
  6. Scopus by Title (Ref)

Hepatitis Monthly

Official Journal of Research Center for Gastroenterology and Liver Diseases

Home
Current IssueAccepted ManuscriptsAll IssuesIn Press ArticlesSearch
Instructions
Journal InformationBoards and committeesIndexing and Listing SourcesJournal MetricsOpen Peer Review (OPR)Publication Ethics and Malpractice StatementReviewer and AE Registration FormSupportContact Us
APC
Authors GuideSubmit Manuscript

Scopus by Title (Ref)


1. Triple Combination with Direct Acting Antivirals in the Treatment of Hepatitis C Does not Prolong the QT Interval

- Šimka J. , et al.

2. Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C−infected patients with thalassemia

- Khosravi A. , et al.

3. Cardiac Disorder in Chronic Hepatitis C

- Silva Rezende A.G.d. , et al.

4. Persistently altered liver test results in hepatitis C patients after sustained virological response with direct-acting antivirals

- Olveira A. , et al.

5. Pegylated Interferon-α Plus Ribavirin Therapy Improves Left Ventricular Diastolic Dysfunction in Patients With Chronic Hepatitis C Attaining Sustained Virological Response

- Mohammed A.Q. , et al.

6. Non-sustained ventricular tachycardia during treatment of genotype 3 chronic hepatitis C - A case report

- Poliwczak A.R. , et al.

7. Cardiovascular disease and hepatitis C virus infection: An irrelevant statement or a hot relationship?

- Katsi V. , et al.

8. Dilated cardiomyopathy and hypothyroidism associated with pegylated interferon and ribavirin treatment for chronic hepatitis C: Case report and literature review

- Zhao W. , et al.

9. Factors associated with treatment interruption for hepatitis C

- De Melo L.O.R. , et al.

10. Some considerations about cardiac toxicity of combination therapy for chronic hepatitis C

- Karbasi-Afshar R. , et al.

HomeInstructionsAPC

Articles

  • Current Issue
  • Accepted Manuscripts
  • All Issues
  • In Press Articles
  • Search

About Journal

  • Journal Information
  • Boards and committees
  • Indexing and Listing Sources
  • Journal Metrics
  • Open Peer Review (OPR)
  • Publication Ethics and Malpractice Statement
  • Reviewer and AE Registration Form
  • Support
  • Contact Us
Support
Submit a Ticket
BrieflandsBrieflands

Science, Technical, Medical Publisher, Since 2007

All rights reserved by Brieflands, 2026.

Powered by Neoscriber.